Claudio Acevedo
Impact in
-
- Antibiotic Use and Resistance
-
- Nosocomial Infections in ICU
Papers in
-
- Sepsis Diagnosis and Treatment 3
- Pneumonia and Respiratory Infections 2
-
- COVID-19 Clinical Research Studies 3
- Antimicrobial Resistance in Staphylococcus 1
- Co-authors
- Silvio D. Brugger (9 shared papers)Daniel A. Hofmaenner (6 shared papers)Pedro David Wendel‐Garcia (5 shared papers)Philipp K. Buehler (6 shared papers)Matthias P. Hilty (4 shared papers)Annelies S. Zinkernagel (6 shared papers)Reto A. Schuepbach (5 shared papers)Alejandro Gómez-Mejía (5 shared papers)
- Journals
- PLoS Pathogens (1 paper)Oncotarget (1 paper)Cell Reports Medicine (1 paper)Annals of Clinical Microbiology and Antimicrobials (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- SwitzerlandNetherlands
In The Last Decade
Claudio Acevedo
11 papers receiving 202 citations
Peers
Comparison fields: 5 of 56
- Applied Microbiology and Biotechnology 40
- Critical Care and Intensive Care Medicine 52
- Microbiology 4
- Infectious Diseases 87
- Molecular Medicine 19
Countries citing papers authored by Claudio Acevedo
This map shows the geographic impact of Claudio Acevedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Acevedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Acevedo more than expected).
Fields of papers citing papers by Claudio Acevedo
This network shows the impact of papers produced by Claudio Acevedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Acevedo. The network helps show where Claudio Acevedo may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudio Acevedo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 56 | |
| 2 | 2021 | 41 | |
| 3 | 2021 | 24 | |
| 4 | 2022 | 19 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 14 | |
| 7 | 2015 | 10 | |
| 8 | 2021 | 7 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 5 |
About Claudio Acevedo
Claudio Acevedo is a scholar working on Epidemiology, Infectious Diseases, Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Surgery, having authored 11 papers that have together received 204 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Sepsis Diagnosis and Treatment (3 papers), Antibiotic Use and Resistance (3 papers), Nosocomial Infections in ICU (2 papers), Pneumonia and Respiratory Infections (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Long-Term Effects of COVID-19 (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (40 citations), Critical Care and Intensive Care Medicine (52 citations), Microbiology (4 citations), Infectious Diseases (87 citations) and Molecular Medicine (19 citations). Claudio Acevedo has collaborated with scholars based in Switzerland and Netherlands. Frequent co-authors include Silvio D. Brugger, Daniel A. Hofmaenner, Pedro David Wendel‐Garcia, Philipp K. Buehler, Matthias P. Hilty, Annelies S. Zinkernagel, Reto A. Schuepbach, Alejandro Gómez-Mejía, Srikanth Mairpady Shambat and Federica Andreoni. Their work appears in journals such as PLoS Pathogens, Oncotarget, Cell Reports Medicine, Annals of Clinical Microbiology and Antimicrobials and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.